BioProcess International™ Conference & Exhibition : Home

Choose your language

Document Title

Event Overview

Did You Know?

North Carolina has the nation's third largest biotech industry for four years in a row, according to Ernst & Youngs 2007 global industry survey, Beyond Borders.
More than 50 companies manufacturing biologics, pharmaceuticals and diagnostics already call North Carolina home. These companies -- Biogen Idec, GlaxoSmithKline, Novozymes, Pfizer Animal Health, Talecris, and Wyeth -- operate some of the largest or most unique facilities of their kind.

Develop Valuable Partnerships and Gain a Competitive Advantage for Continuous Improvement

The biopharmaceutical industry has embraced the BioProcess International™ Conference and Exhibition as its premier event. BPI is your key to a week of intensive learning, evocative discussions, enjoyable networking and solutions to your service, equipment and raw materials needs. This is the one place where you know you will have the opportunity to meet with the key players in the field.

From high-level strategy to nuts and bolts technical case studies, the program digs deep into important areas where regulatory, technical and market forces are changing the field. Whether you work with mAbs, recombinant proteins, vaccines, or other types of biologics - at a large or small company - here you will find presentations and discussions which will answer your specific information requirements.

4 Comprehensive Tracks

Keynote Presentations

Reinventing Biologics Pharmaceutical Development and Marketed Product Support Paul F. McKenzie Vice President, BIO Pharmaceutical Development and Marketed Product Support, Centocor R&D	ObamaCare: Stimulus Spending, System Reform and Market Change J.D. Kleinke Medical Economist and Author, Oxymorons: The Myth of a U.S. Health Care System	Future Trends in Biopharmaceutical Operations and Facilities Johannes Roebers, Ph.D. Senior Vice President, Head of Biologic Strategy, Planning & Operations, Elan Pharma International Limited, Ireland
Operational Excellence: The Opportunity in the Life Sciences Industry G.K. Raju, Ph.D. Executive Director, Manufacturing Initiatives, MIT Center for Biomedical Innovations	Integrating New Technologies in Upstream and Downstream Processing Konstantin Konstantinov, Ph.D. Vice President, Technology Development, Genzyme Corp.	In Pursuit of Quality: Continual Improvement, Innovation, and Regulatory Oversight Ali M. Afnán, Ph.D. Senior Staff Fellow, OPS, CDER, US FDA